Ty Nielson
Medical · Phoenix, AZNPI 1871988980
Payments from drug & device makers
Across 815 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$3K
- Incyte Corporation$2K
- Regeneron Healthcare Solutions, Inc.$2K
- AbbVie$2K
- Johnson & Johnson$1K
- Novartis$1K
- plus $6K from 23 others
What the payments were for
- Consulting fees$9105%
- Speaking & faculty fees$8005%
- Food & beverage$15,59489%
- Education$2702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 96 | $2,681 |
| Incyte Corporation | 81 | $2,099 |
| Regeneron Healthcare Solutions, Inc. | 74 | $2,010 |
| AbbVie | 93 | $1,784 |
| Johnson & Johnson | 88 | $1,499 |
| Novartis | 48 | $1,175 |
| Pfizer | 54 | $907 |
| Sun Pharmaceutical Industries Inc. | 33 | $702 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 51 | $647 |
| Journey Medical Corporation | 7 | $610 |
| Lilly USA, LLC | 27 | $572 |
| E.r. Squibb & Sons, L.L.C. | 35 | $539 |
| UCB, Inc. | 18 | $436 |
| Galderma Laboratories, L.p. | 25 | $396 |
| Sanofi | 9 | $266 |
| Arcutis Biotherapeutics, Inc. | 12 | $229 |
| Dermavant Sciences, Inc. | 12 | $198 |
| Amgen | 9 | $170 |
| VYNE Pharmaceuticals Inc. | 5 | $123 |
| Biofrontera Inc. | 4 | $96 |
| Mayne Pharma Commercial LLC | 14 | $88 |
| EPI Health, LLC | 4 | $86 |
| Almirall LLC | 4 | $82 |
| Organon | 6 | $69 |
| Verrica Pharmaceuticals Inc. | 2 | $36 |
| Botanix SB Inc | 1 | $23 |
| LNHC, Inc | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,573 in reported general payments places this provider in the 95th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 41 | $1,114 |
| Fluorouracil | 18 | $1,100 |
| Metronidazole | 14 | $739 |
| Doxycycline Hyclate | 29 | $663 |
| Ketoconazole | 44 | $579 |
| Triamcinolone Acetonide | 30 | $256 |
Paid to pharmacies, not to this prescriber.
Other medical in Phoenix
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
- Jennifer KiserPhoenix$53K
- Lakeisha ColterPhoenix$48K
- Amy IngersollPhoenix$42K
- Brittany SilvermanPhoenix$16K
- John RimerPhoenix$15K
- Rana AoufePhoenix$14K
- Adam SchwartzPhoenix$12K
- Rebecca RowenPhoenix$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.